参考文献/References:
[1]石磊,安梓铭,冯琴.联合检测血清AFP、AFP-L3％和PIVKA-Ⅱ水平早期诊断和判断原发性肝癌患者预后临床价值探讨[J].实用肝脏病杂志,2023,26(3):404-407.[2]周梅,吴菊,郭清萍,等.血清AFP、CA125、CEA在原发性肝癌鉴别及肿瘤分期中的应用[J].海南医学,2023,34(6):836-840.[3]黎增辉.血清AFP-L3％、CA125、CA199和IL-6变化与乙肝后肝硬化和癌变的相关性研究[J].临床输血与检验,2019,21(5):535-539.[4]杨结,谢万珍,刘树业.血清肿瘤标志物联合检测在原发性肝癌诊断中的价值研究[J].中国中西医结合外科杂志,2022,28(3):352-358.[5]林勇,曾欣,胡平方.中国肝硬化临床诊治共识意见[J].临床肝胆病杂志,2023,39(9):2057-2073.[6]中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗指南(2022年版)[J].中国实用外科杂志,2022,42(3):241-273.[7]El-Maksoud MA,Habeeb MR,Ghazy HF,et al.Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma[J].Eur J Gastroenterol Hepatol,2019,31(6):716-722.[8]崔怀中,王莹,徐爱芳,等.血清甲胎蛋白及其L3异质体联合检测在慢性乙型肝炎相关性肝癌诊断中的价值研究[J].中国卫生检验杂志,2021,31(24):2998-3000.[9]潘春燕,李凤菊,陶亚飞,等.磁共振扩散加权成像联合血清AFP、CA125、CEA、CA199检测在早期原发性肝癌中的诊断价值研究[J].现代生物医学进展,2021,21(23):4527-4530,4553.[10]周佳平.AFP、CEA、CA50及CA199联合检测在原发性肝癌鉴别诊断中的应用研究[J].中西医结合肝病杂志,2021,31(10):927-929.[11]王欣,王秀云,王丰艳,等.血清AFP和CA199浓度与肝癌合并肝硬化患者肝脏切除后转归的关系[J].湖南师范大学学报(医学版),2021,18(4):248-251.[12]陈昌达,陈超群,卢盛祥,等.AFP、AFU、CEA和CA19-9联合检测对原发性肝癌的诊断价值[J].海南医学,2021,32(4):485-487.[13]Spadaccini M,Lleo A,Ceriani R,et al.Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era[J].Hepatobiliary Pancreat Dis Int,2018,17(6):570-574.[14]裴建华.血清甲胎蛋白、癌胚抗原、CA153、CA199联合检测在肝癌诊断中的应用价值[J].解放军预防医学杂志,2020,38(10):29-32.[15]熊晓波,杨柳,李艳.血清CRP与肿瘤标志物的联合检测对原发性肝癌诊断中的应用价值[J].实用癌症杂志,2020,35(9):1437-1440.[16]胡广梅,钟日辉,黄利思,等.甲胎蛋白、α-L-岩藻糖苷酶、糖链抗原125血清检测在原发性肝癌筛查及鉴别诊断中的价值[J].中国卫生检验杂志,2020,30(17):2052-2055.[17]贺娟,肖伟利,任志宏,等.血清AFP、CEA与肝癌患者临床病理分期和预后的关系及其诊断价值分析[J].现代生物医学进展,2020,20(8):1501-1505.[18]何静,程义壮,姜徽,等.血清AFP、AFP-L3及GP73在原发性肝癌诊断和鉴别诊断中的应用评价[J].标记免疫分析与临床,2020,27(2):190-194.[19]张莹,李静,徐有青.血清CEA、AFP、CA199、CA125联合检测诊断胃癌的ROC曲线分析及临床指导意义[J].湖南师范大学学报(医学版),2022,19(4):84-87.[20]崔琦,董延娥,霍云龙,等.多种血清肿瘤标记物联合检测在原发性肝癌临床诊断中的价值[J].现代肿瘤医学,2019,27(18):3267-3270.[21]张立营,赵丽艳,赵权.GP73和AFP联合检测在原发性肝癌诊断中的价值[J].中国医药生物技术,2019,14(1):43-45.[22]颜丽,魏莲花,齐发梅,等.血清TSGF,AFP,CEA和FER联合检测在肝脏恶性肿瘤诊断中的应用价值[J].现代检验医学杂志,2018,33(5):24-26,141.[23]邹瑞.原发性肝癌患者血清HCY、AFU、CA199联合检测的临床价值[J].肝脏,2018,23(5):421-423.[24]陈平,樊卫,刘玲.血清AFP、CEA、CA199联合检测原发性肝癌的灵敏度分析[J].医学临床研究,2020,37(7):1090-1092.[25]王海东,李宁侠,董恒利,等.血清肿瘤标志物联合血常规检测在原发性肝癌中的诊断价值[J].中国肿瘤临床与康复,2022,29(5):541-543.
相似文献/References:
[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(17):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Journal of Medical Information,2018,31(17):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(17):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(17):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(17):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的
相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(17):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(17):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[8]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(17):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(17):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]